• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration.沉默信息调节因子1(SIRT1)在非小细胞肺癌(NSCLC)的脑转移组织中高表达,并对NSCLC细胞迁移起正向调节作用。
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2357-65. eCollection 2013.
2
MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.微小RNA-330-3p通过激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)信号通路,作用于谷氨酸受体离子otropic AMPA 3型(GRIA3),从而促进非小细胞肺癌的细胞侵袭和转移。
J Hematol Oncol. 2017 Jun 19;10(1):125. doi: 10.1186/s13045-017-0493-0.
3
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.组蛋白去甲基化酶 JARID1B/KDM5B 促进非小细胞肺癌的侵袭性,并可作为一个良好的预后预测因子。
Clin Epigenetics. 2018 Aug 9;10(1):107. doi: 10.1186/s13148-018-0533-9.
4
SIRT1 promotes metastasis of human osteosarcoma cells.SIRT1促进人骨肉瘤细胞的转移。
Oncotarget. 2016 Nov 29;7(48):79654-79669. doi: 10.18632/oncotarget.12916.
5
Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.黄芩素,一种中药,通过激活 SIRT1/AMPK 信号通路抑制人非小细胞肺癌(NSCLC)细胞 A549 和 H1299 的增殖和迁移。
Med Sci Monit. 2018 Apr 10;24:2126-2133. doi: 10.12659/msm.909627.
6
HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin.组蛋白去乙酰化酶2通过上调纤连蛋白促进非小细胞肺癌细胞的迁移和侵袭。
Biomed Pharmacother. 2016 Dec;84:284-290. doi: 10.1016/j.biopha.2016.09.030. Epub 2016 Sep 22.
7
GAP43, a novel metastasis promoter in non-small cell lung cancer.GAP43,一种非小细胞肺癌中的新型转移促进因子。
J Transl Med. 2018 Nov 12;16(1):310. doi: 10.1186/s12967-018-1682-5.
8
Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer.核内组蛋白去乙酰化酶6通过抑制核因子κB/基质金属蛋白酶2来抑制侵袭,且与非小细胞肺癌转移呈负相关。
Oncotarget. 2015 Oct 6;6(30):30263-76. doi: 10.18632/oncotarget.4749.
9
Hypoxia-Induced Regulates the Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells.低氧诱导因子调节非小细胞肺癌细胞的增殖和转移。
Int J Mol Sci. 2021 Apr 21;22(9):4302. doi: 10.3390/ijms22094302.
10
Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.二甲双胍和替莫唑胺-6 通过非小细胞肺癌细胞中 LKB1 非依赖性 SIRT1 下调协同诱导细胞凋亡。
J Cell Mol Med. 2019 Apr;23(4):2872-2889. doi: 10.1111/jcmm.14194. Epub 2019 Feb 1.

引用本文的文献

1
The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy.SIRT1在自噬和耐药性中的作用:揭示癌症治疗中的新靶点和潜在生物标志物。
Front Pharmacol. 2024 Sep 30;15:1469830. doi: 10.3389/fphar.2024.1469830. eCollection 2024.
2
Emerging role of sirtuins in non‑small cell lung cancer (Review).沉默信息调节因子 2 相关酶 1 在非小细胞肺癌中的作用(综述)。
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8786. Epub 2024 Aug 2.
3
The impact of vitamin D on cancer: A mini review.维生素 D 对癌症的影响:小型综述。
J Steroid Biochem Mol Biol. 2023 Jul;231:106308. doi: 10.1016/j.jsbmb.2023.106308. Epub 2023 Apr 11.
4
SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.SIRT1表达是食管鳞状细胞癌中一个有前景的预后生物标志物:一项系统评价和荟萃分析。
Cancer Diagn Progn. 2022 Mar 3;2(2):126-133. doi: 10.21873/cdp.10086. eCollection 2022 Mar-Apr.
5
Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.用于脑转移瘤诊断、预防和治疗的新兴生物标志物——从生物学特性到临床应用价值
Diseases. 2022 Feb 3;10(1):11. doi: 10.3390/diseases10010011.
6
MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA.微小 RNA-326 通过抑制组蛋白去乙酰化酶 SIRT1 介导的 HIF1α 和上调 VEGFA 来损害非小细胞肺癌的化疗耐药性。
Bioengineered. 2022 Mar;13(3):5685-5699. doi: 10.1080/21655979.2021.1993718.
7
MicroRNA-217 inhibits the proliferation and invasion, and promotes apoptosis of non-small cell lung cancer cells by targeting sirtuin 1.微小RNA-217通过靶向沉默调节蛋白1抑制非小细胞肺癌细胞的增殖和侵袭,并促进其凋亡。
Oncol Lett. 2021 May;21(5):386. doi: 10.3892/ol.2021.12647. Epub 2021 Mar 17.
8
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an systems biology-based approach.使用基于系统生物学的方法对第二代ALK抑制剂布加替尼和阿来替尼作为ALK阳性非小细胞肺癌一线治疗进行头对头评估。
Oncotarget. 2021 Feb 16;12(4):316-332. doi: 10.18632/oncotarget.27875.
9
Primary tumor and metastasis-sectioning the different steps of the metastatic cascade.原发性肿瘤与转移——剖析转移级联反应的不同步骤
Transl Lung Cancer Res. 2020 Oct;9(5):2277-2300. doi: 10.21037/tlcr-20-175.
10
ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer.活性氧诱导的SIRT2上调有助于卵巢癌对顺铂的敏感性。
Antioxidants (Basel). 2020 Nov 16;9(11):1137. doi: 10.3390/antiox9111137.

本文引用的文献

1
PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.PIASy 介导低氧诱导的卵巢癌细胞中 SIRT1 的转录抑制和上皮间质转化。
J Cell Sci. 2013 Sep 1;126(Pt 17):3939-47. doi: 10.1242/jcs.127381. Epub 2013 Jul 10.
2
EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.表皮生长因子受体通过 MAPK 激活间质上皮转化因子以增强非小细胞肺癌的侵袭和脑转移。
Cancer Res. 2013 Aug 15;73(16):5053-65. doi: 10.1158/0008-5472.CAN-12-3775. Epub 2013 Jun 21.
3
MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.miR-204 下调 SIRT1 并逆转 SIRT1 诱导的胃癌细胞上皮-间充质转化、抗失巢凋亡和侵袭。
BMC Cancer. 2013 Jun 14;13:290. doi: 10.1186/1471-2407-13-290.
4
Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis.脑内皮细胞紧密连接中的连接黏附分子与脑转移。
Anticancer Res. 2013 Jun;33(6):2353-9.
5
MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.MicroRNA-29c 通过直接靶向肝癌中的致癌 SIRT1 发挥肿瘤抑制作用。
Oncogene. 2014 May 15;33(20):2557-67. doi: 10.1038/onc.2013.216. Epub 2013 Jun 3.
6
A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.SUMOylation 依赖性途径调节 SIRT1 转录和肺癌转移。
J Natl Cancer Inst. 2013 Jun 19;105(12):887-98. doi: 10.1093/jnci/djt118. Epub 2013 May 23.
7
Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.SIRT1 和 cortactin 的表达与非小细胞肺癌的进展相关。
Pathol Res Pract. 2013 Jun;209(6):365-70. doi: 10.1016/j.prp.2013.03.011. Epub 2013 Apr 15.
8
αv-Integrin isoform expression in primary human tumors and brain metastases.αv 整合素同种型在原发性人类肿瘤和脑转移中的表达。
Int J Cancer. 2013 Nov 15;133(10):2362-71. doi: 10.1002/ijc.28267. Epub 2013 Jun 10.
9
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.趋化因子受体 4/趋化因子配体 12 轴在非小细胞肺癌(NSCLC)中的病理作用和治疗潜力。
Theranostics. 2013;3(1):26-33. doi: 10.7150/thno.4922. Epub 2013 Jan 13.
10
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.厄洛替尼联合全脑放疗治疗非小细胞肺癌脑转移患者的 II 期临床试验。
J Clin Oncol. 2013 Mar 1;31(7):895-902. doi: 10.1200/JCO.2011.40.1174. Epub 2013 Jan 22.

沉默信息调节因子1(SIRT1)在非小细胞肺癌(NSCLC)的脑转移组织中高表达,并对NSCLC细胞迁移起正向调节作用。

SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration.

作者信息

Han Lin, Liang Xiao-Hua, Chen Li-Xin, Bao Shi-Min, Yan Zhi-Qiang

机构信息

The Experimental Animal Center, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences Shanghai, China.

出版信息

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2357-65. eCollection 2013.

PMID:24228097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3816804/
Abstract

Brain metastases are a frequent and ongoing major complication of non-small cell lung cancer (NSCLC). To deepen our understanding to the underlying mechanisms by which NSCLC cells metastasize to brain and hence to improve the therapy, a high throughput RNAi screening with shRNA library of 153 epigenetic genes was subjected to A549, a NSCLC cell line with high migration ability, to examine the effects of these genes on cell migration by wound-healing assay. The screening results showed that knockdown of 2 genes (KDM5B and SIRT1) dramatically and specifically inhibits A549 migration but not affects the proliferation, which was subsequently confirmed through transwell migration assay. Furthermore, SIRT1 is found to be highly expressed in brain metastasis tissues of NSCLC, compared to the NSCLC tissues, suggesting that SIRT1 may play roles in brain metastasis of NSCLC. The relationship between SIRT1 expression and cell migration ability was further investigated in three NSCLC cell lines and the result indicated that SIRT1 expression is tightly correlated with cell migration ability. Collectively, our work provides potential biomarker and therapeutic target for brain metastasis of NSCLC.

摘要

脑转移是非小细胞肺癌(NSCLC)常见且持续存在的主要并发症。为了深入了解NSCLC细胞转移至脑的潜在机制从而改善治疗方法,我们使用包含153个表观遗传基因的shRNA文库对具有高迁移能力的NSCLC细胞系A549进行了高通量RNA干扰筛选,通过伤口愈合试验检测这些基因对细胞迁移的影响。筛选结果显示,敲低2个基因(KDM5B和SIRT1)可显著且特异性地抑制A549细胞迁移,但不影响其增殖,随后通过Transwell迁移试验得以证实。此外,与NSCLC组织相比,SIRT1在NSCLC脑转移组织中高表达,提示SIRT1可能在NSCLC脑转移中发挥作用。我们在三种NSCLC细胞系中进一步研究了SIRT1表达与细胞迁移能力之间的关系,结果表明SIRT1表达与细胞迁移能力密切相关。总体而言,我们的研究为NSCLC脑转移提供了潜在的生物标志物和治疗靶点。